# FDGL Dose-Finding Study for Diabetic Neuropathy

> **NCT07117942** · PHASE2 · COMPLETED · sponsor: **Helwan University** · enrollment: 485 (actual)

## Conditions studied

- Diabetic Neuropathy

## Interventions

- **DRUG:** Fermented Deglycyrrhizinated Licorice (FDGL)

## Key facts

- **NCT ID:** NCT07117942
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-12
- **Primary completion:** 2021-06-18
- **Final completion:** 2023-04-10
- **Target enrollment:** 485 (ACTUAL)
- **Last updated:** 2025-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07117942

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07117942, "FDGL Dose-Finding Study for Diabetic Neuropathy". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT07117942. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*